Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20210710001
TCTR20210710001
Not yet recruiting
Not Applicable

Treatments and outcomes of ovarian cancers in Srinagarind hospital: A retrospective descriptive analysis

MD research KK0 sites260 target enrollmentJuly 10, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTreatments and outsomes in pateints with advance ovarian cancersOvarian cancers, Fallopain tube cancers, Peritoneal

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Treatments and outsomes in pateints with advance ovarian cancers
Sponsor
MD research KK
Enrollment
260
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2021
End Date
December 29, 2021
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
MD research KK

Eligibility Criteria

Inclusion Criteria

  • •Women was diagnosed with advance ovarian cancers, fallopian tubes cancers or peritoneal carcinoma in Srinagarind hospital

Exclusion Criteria

  • •Incomplete data collection
  • •Loss follow up

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparising result of histopathology examination to frozen section for diagnosing ovarian malignancyHealth Condition 1: C569- Malignant neoplasm of unspecifiedovary
CTRI/2024/04/065770JAWAHAR LAL NEHRU MEDICAL COLLEGE
Completed
Not Applicable
Treatments and outcomes of endometrial cancers in Srinagarind HospitalComparing treatments in real-life practice with guidelineKnowing outcomes of them when treated in our hospitaltreatments outcomes endometrial cancers
TCTR20220131004Faculty of Medicine, Khon Kaen University277
Not yet recruiting
Not Applicable
Predict Response Of Drugs In Ovarian Cancer Treatment Using Organoidsepithelial ovariancarcinomaovarian cancer10038594
NL-OMON56484niversitair Medisch Centrum Utrecht239
Completed
Phase 3
Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD)/ Carboplatin versus without in Patients with Advanced Ovarian CancerAdvanced ovarian cancerCancer - Ovarian and primary peritoneal
ACTRN12607000329460Chang Gung Memorial Hospital122
Terminated
Not Applicable
Improving communication about treatment options for asymptomatic ovarian cancer patients with rising cancer antigen 125 (CA-125): A randomised controlled trial of a Decision AidCommunication about treatment options and decision making for women with asymptomatic ovarian cancer and rising CA-125 levels.Cancer - Ovarian and primary peritoneal
ACTRN12609001035213Centre for Medical Psychology and Evidence-based Decision-making178